| 000 | 01441 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250518024701.0 | ||
| 264 | 0 | _c20200619 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1557-8992 | ||
| 024 | 7 |
_a10.1089/cap.2018.0145 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStrawn, Jeffrey R | |
| 245 | 0 | 0 |
_aSwitching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy. _h[electronic resource] |
| 260 |
_bJournal of child and adolescent psychopharmacology _c05 2019 |
||
| 300 |
_a250-255 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aCitalopram _xadverse effects |
| 650 | 0 | 4 |
_aDepressive Disorder, Major _xdrug therapy |
| 650 | 0 | 4 |
_aDepressive Disorder, Treatment-Resistant _xdrug therapy |
| 650 | 0 | 4 |
_aFluoxetine _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMonte Carlo Method |
| 650 | 0 | 4 |
_aParoxetine _xadverse effects |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMills, Jeffrey A | |
| 700 | 1 | _aCroarkin, Paul E | |
| 773 | 0 |
_tJournal of child and adolescent psychopharmacology _gvol. 29 _gno. 4 _gp. 250-255 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/cap.2018.0145 _zAvailable from publisher's website |
| 999 |
_c29417865 _d29417865 |
||